Your browser doesn't support javascript.
loading
Scoping Review of Factors Associated with Stem Cell Mobilization and Collection in Allogeneic Stem Cell Donors.
Peck, Rachel C; Knapp-Wilson, Amber; Burley, Kate; Dorée, Carolyn; Griffin, James; Mumford, Andrew D; Stanworth, Simon; Sharplin, Kirsty.
Afiliación
  • Peck RC; NHS Blood and Transplant, Bristol, United Kingdom; Faculty of Life Sciences, University of Bristol, Bristol, United Kingdom. Electronic address: rachel.peck@bristol.ac.uk.
  • Knapp-Wilson A; Faculty of Life Sciences, University of Bristol, Bristol, United Kingdom.
  • Burley K; Faculty of Life Sciences, University of Bristol, Bristol, United Kingdom.
  • Dorée C; Systematic Review Initiative, NHS Blood and Transplant, Oxford, United Kingdom.
  • Griffin J; NHS Blood and Transplant, Bristol, United Kingdom.
  • Mumford AD; Faculty of Life Sciences, University of Bristol, Bristol, United Kingdom.
  • Stanworth S; NHS Blood and Transplant, Bristol, United Kingdom; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Sharplin K; NHS Blood and Transplant, Bristol, United Kingdom.
Transplant Cell Ther ; 2024 Jun 06.
Article en En | MEDLINE | ID: mdl-38851322
ABSTRACT
There is wide interindividual variation in the efficacy of CD34+ cell mobilization and collection in healthy allogenic hematopoietic stem cell donors. Donor characteristics, blood cell counts, and various factors related to mobilization and collection have been associated with blood CD34+ cell count and CD34+ cell yield after granulocyte colony-stimulating factor (G-CSF) mobilization and collection. Given the heterogenous nature of the literature reporting these associations, in this scoping review we clarify the determinants of CD34+ count and yield. Studies published between 2000 and 2023 reporting allogeneic donors undergoing G-CSF mobilization and peripheral blood stem cell (PBSC) collection were evaluated. Eligible studies were those that assessed blood CD34+ cell count or CD34+ cell yield in the first PBSC collection after mobilization with 4 or 5 days of G-CSF treatment. Associations were recorded between these outcomes and donor factors (age, sex, weight, ethnicity), mobilization factors (G-CSF scheduling or dose), collection factors (venous access, processed blood volume [PBV]) or laboratory factors (blood cell counts at baseline or after mobilization). The 52 studies evaluated between 15 and 20,884 donors. Forty-three studies were retrospective, 33 assessed blood CD34+ cell counts, and 39 assessed CD34+ cell yield from PBSCs. Blood CD34+ cell counts consistently predicted CD34+ cell yield. Younger donors usually had higher blood CD34+ cell counts and CD34+ cell yield. Most studies that investigated the effect of donor ancestry found that donors of non-European ancestry had higher blood CD34+ cell counts after mobilization and higher CD34+ cell yields from collection. The poor consensus about the best predictors of blood CD34+ cell count and yield necessitates further prospective studies, particularly of the role of donor ancestry. The current focus on donor sex as a major predictor requires re-evaluation.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transplant Cell Ther Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transplant Cell Ther Año: 2024 Tipo del documento: Article